Russia is willing to help the United States with new coronal vaccine

Russian sources disclosed that Russia was willing to provide help to the United States in the development and production of the new crown vaccine, but the United States refused on the ground of “political reasons”. The US cable day quoted several Russian officials as saying that the Russian side is willing to provide the US side with information on the new crown vaccine that has just been registered by the Russian side, while allowing us pharmaceutical enterprises to produce this type of vaccine in the United States. According to Russian officials, Russia is willing to provide “unprecedented cooperation” to the US side’s “qusu” operation. The “warp speed” operation involves a number of agencies in the United States to accelerate the development of new coronal vaccines and therapies. However, the Russian proposal was rejected. “The U.S. has a general distrust of Russia,” a senior Russian official said. “We believe that this distrust has led to the US’s refusal to accept (Russian) technology, including vaccines, tests and therapies.” Another senior Russian official said: “if our vaccine turns out to be one of the most effective vaccines, we can’t help but ask why the United States does not consider this option more deeply? Why let politics get in the way of access to a vaccine? ” Russian President Vladimir Putin said on the 11th that the new crown vaccine developed by Russia has been registered by the state for the first time, and one of his daughters is one of the vaccinators in the vaccine trial. < / P > < p > the vaccine, named “satellite V”, was developed by Russia’s “gamaliya” National Research Center for epidemiology and microbiology, and has completed the first and second phase of clinical trials. Putin said that this type of vaccine “has passed the necessary tests, can give full play to its function effectively and stably generate antibodies”. However, the vaccine has not yet been put into phase III clinical trials on a larger scale. The third phase is scheduled to start this month for five months, with about 2000 adults vaccinated. About 20 Latin American, Middle East and Asian countries have expressed interest in the new “satellite V” crown vaccine, the Russian Direct Investment Fund said at a news conference on November 11. According to CNN, Russia said some U.S. pharmaceutical companies were also interested in the vaccine, but did not disclose which companies were involved. The U.S. government is focusing on purchasing vaccines from pharmaceutical companies in the United States and Europe. The US side decided that the Russian vaccine was “immature”, a US health official told CNN: “the United States will never use it (Russian vaccine) to test on monkeys, let alone humans.” “They’re doing so little on humans that they can’t be sure if it works on a larger scale,” said a U.S. government adviser. There is a total lack of security data. ” White House press secretary Kelly mcnani said on the 13th that US President Donald Trump has received a briefing from Russia on this type of vaccine. McNair’s third-party clinical trial will be strictly followed. (Hui Xiaoshuang)